NASDAQ:AIPT - Precision Therapeutics News Headlines

Sign in or create an account to add this stock to your watchlist.
$0.8723 +0.05 (+6.08 %)
(As of 01/17/2019 02:41 AM ET)
Previous Close$0.8205
Today's Range$0.8313 - $0.8912
52-Week Range$0.60 - $1.58
Volume96,878 shs
Average Volume47,145 shs
Market Capitalization$10.91 million
P/E RatioN/A
Dividend YieldN/A
Beta1.22

Headlines

Precision Therapeutics (NASDAQ AIPT) News Headlines

Source:
DateHeadline
Contrasting Precision Therapeutics (AIPT) & Zimmer Biomet (ZBH)Contrasting Precision Therapeutics (AIPT) & Zimmer Biomet (ZBH)
www.americanbankingnews.com - January 13 at 11:26 AM
Critical Analysis: ConforMIS (CFMS) and Precision Therapeutics (AIPT)Critical Analysis: ConforMIS (CFMS) and Precision Therapeutics (AIPT)
www.americanbankingnews.com - January 10 at 7:31 PM
Precision Therapeutics (AIPT) and Zimmer Biomet (ZBH) Head-To-Head ComparisonPrecision Therapeutics (AIPT) and Zimmer Biomet (ZBH) Head-To-Head Comparison
www.americanbankingnews.com - January 9 at 1:18 PM
ConforMIS (CFMS) and Precision Therapeutics (AIPT) Critical ComparisonConforMIS (CFMS) and Precision Therapeutics (AIPT) Critical Comparison
www.americanbankingnews.com - January 6 at 7:32 PM
Precision Therapeutics (AIPT) & Align Technology (ALGN) Critical AnalysisPrecision Therapeutics (AIPT) & Align Technology (ALGN) Critical Analysis
www.americanbankingnews.com - December 31 at 1:08 AM
Sientra (SIEN) & Precision Therapeutics (AIPT) Head to Head SurveySientra (SIEN) & Precision Therapeutics (AIPT) Head to Head Survey
www.americanbankingnews.com - December 28 at 7:26 PM
Reviewing WILLIAM DEMANT/ADR (WILYY) and Precision Therapeutics (AIPT)Reviewing WILLIAM DEMANT/ADR (WILYY) and Precision Therapeutics (AIPT)
www.americanbankingnews.com - December 28 at 3:18 AM
Precision Therapeutics Inc. (AIPT) CEO Dr. Carl Schwartz on Q3 2018 Results - Earnings Call TranscriptPrecision Therapeutics Inc. (AIPT) CEO Dr. Carl Schwartz on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 17 at 10:16 AM
Precision Therapeutics Reports Third Quarter 2018 Financial ResultsPrecision Therapeutics Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 15 at 10:39 AM
Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian CancerHelomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer
finance.yahoo.com - November 14 at 10:16 AM
Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018
finance.yahoo.com - November 8 at 10:44 AM
BRIEF-Precision Therapeutics Secures Rights To Novel Technology Designed To Develop Cancer DrugsBRIEF-Precision Therapeutics Secures Rights To Novel Technology Designed To Develop Cancer Drugs
www.msn.com - November 7 at 10:59 AM
Precision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its MutationPrecision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutation
finance.yahoo.com - November 7 at 10:59 AM
Precision Therapeutics’ CEO Talks with Uptick Newswire’s Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and What’s on the HorizonPrecision Therapeutics’ CEO Talks with Uptick Newswire’s Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and What’s on the Horizon
finance.yahoo.com - November 5 at 3:31 PM
Filing under Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Precision Therapeutics Inc.: SEC File Nos. 001-36790; and 333-221966Filing under Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Precision Therapeutics Inc.: SEC File Nos. 001-36790; and 333-221966
feeds.benzinga.com - October 29 at 10:10 PM
Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhDPrecision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD
finance.yahoo.com - October 11 at 10:00 AM
Precision Therapeutics sells first Streamway in Europe; shares up 9%Precision Therapeutics sells first Streamway in Europe; shares up 9%
seekingalpha.com - September 27 at 11:58 AM
Precision Therapeutics Secures First STREAMWAY System Sale in EuropePrecision Therapeutics Secures First STREAMWAY System Sale in Europe
finance.yahoo.com - September 27 at 11:58 AM
Dr. Bob Murphy, Head of Computational Biology at Carnegie Mellon University, Joins Precision Therapeutics’ Scientific Advisory BoardDr. Bob Murphy, Head of Computational Biology at Carnegie Mellon University, Joins Precision Therapeutics’ Scientific Advisory Board
finance.yahoo.com - September 26 at 10:54 AM
Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory BoardPrecision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board
finance.yahoo.com - September 11 at 10:56 AM
Precision Therapeutics Forms Scientific Advisory Board to Advance its Strategy in the Precision Medicine SectorPrecision Therapeutics Forms Scientific Advisory Board to Advance its Strategy in the Precision Medicine Sector
finance.yahoo.com - September 6 at 11:00 AM
Precision Therapeutics Inc. (AIPT) CEO Carl Schwartz on Q2 2018 Results - Earnings Call TranscriptPrecision Therapeutics Inc. (AIPT) CEO Carl Schwartz on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 15 at 10:43 AM
Precision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New ‘HelomicsDiscover’ Program to Drive Forward the Next Generation of Precision Cancer TherapiesPrecision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New ‘HelomicsDiscover’ Program to Drive Forward the Next Generation of Precision Cancer Therapies
finance.yahoo.com - August 14 at 11:01 AM
Precision Therapeutics to Hold Business Update Conference Call on August 14, 2018Precision Therapeutics to Hold Business Update Conference Call on August 14, 2018
finance.yahoo.com - August 9 at 11:00 AM
Precision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights PlatformPrecision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platform
finance.yahoo.com - August 9 at 11:00 AM
Precision Therapeutics Making Rapid Progress with Both Personalized Medicine and Unique Medical Waste Disposal SystemPrecision Therapeutics Making Rapid Progress with Both Personalized Medicine and Unique Medical Waste Disposal System
finance.yahoo.com - August 7 at 3:26 PM
German Stock Exchange approves delisting request of Precision TherapeuticsGerman Stock Exchange approves delisting request of Precision Therapeutics
seekingalpha.com - August 2 at 11:17 AM
Precision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment StrategiesPrecision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategies
finance.yahoo.com - July 17 at 3:24 PM
Precision Therapeutics nabs European patent covering Streamway; shares up 10%Precision Therapeutics nabs European patent covering Streamway; shares up 10%
seekingalpha.com - July 14 at 5:45 PM
Precision Therapeutics Inc. (AIPT) Secures European Patent for STREAMWAY System Covering Automated, Direct-to-Drain Medical Fluid DisposalPrecision Therapeutics Inc. (AIPT) Secures European Patent for STREAMWAY System Covering Automated, Direct-to-Drain Medical Fluid Disposal
www.streetinsider.com - July 14 at 5:45 PM
Precision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal SystemPrecision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal System
feeds.benzinga.com - July 12 at 8:09 PM
Precision Therapeutics Signs Definitive Merger Agreement with Helomics Holding CorporationPrecision Therapeutics Signs Definitive Merger Agreement with Helomics Holding Corporation
feeds.benzinga.com - June 28 at 8:16 PM
Precision Therapeutics Launches New WebsitePrecision Therapeutics Launches New Website
finance.yahoo.com - May 31 at 9:09 AM
Precision Therapeutics (AIPT) CEO Carl Schwartz on Q1 2018 Results - Earnings Call TranscriptPrecision Therapeutics' (AIPT) CEO Carl Schwartz on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 16 at 8:40 AM
Precision Therapeutics Reports First Quarter 2018 Financial ResultsPrecision Therapeutics Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 16 at 8:40 AM
Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018
finance.yahoo.com - May 10 at 3:23 PM
Precision Therapeutics to Hold Business Update Conference Call on May 15, 2018Precision Therapeutics to Hold Business Update Conference Call on May 15, 2018
finance.yahoo.com - May 8 at 3:22 PM
CORRECTING and REPLACING - Precision Therapeutics Releases Highlights from FY 2017 Business Update CallCORRECTING and REPLACING - Precision Therapeutics Releases Highlights from FY 2017 Business Update Call
finance.yahoo.com - April 5 at 9:21 AM
Precision Therapeutics Releases Highlights from FY 2017 Business Update CallPrecision Therapeutics Releases Highlights from FY 2017 Business Update Call
finance.yahoo.com - April 4 at 3:20 PM
Precision Therapeutics is the First Company to Grow Cancer Cells in the Lab That React Like Tumors Inside the Body -- CEOLIVE.TVPrecision Therapeutics is the First Company to Grow Cancer Cells in the Lab That React Like Tumors Inside the Body -- CEOLIVE.TV
finance.yahoo.com - April 4 at 3:20 PM
Precision Therapeutics Reports Fiscal Year 2017 Financial ResultsPrecision Therapeutics Reports Fiscal Year 2017 Financial Results
finance.yahoo.com - April 3 at 7:21 AM
Precision Therapeutics to Hold Business Update Conference Call on April 2, 2018Precision Therapeutics to Hold Business Update Conference Call on April 2, 2018
finance.yahoo.com - March 26 at 3:19 PM
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour DiscoveryPrecision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery
finance.yahoo.com - March 16 at 6:48 AM
Precision Therapeutics Increases Equity Stake in Helomics to 25%Precision Therapeutics Increases Equity Stake in Helomics to 25%
finance.yahoo.com - March 15 at 7:07 AM
Precision Therapeutics Appoints Kevin Hungerford as Vice President of Sales and MarketingPrecision Therapeutics Appoints Kevin Hungerford as Vice President of Sales and Marketing
finance.yahoo.com - March 13 at 6:50 AM
Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor ModelsPrecision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models
finance.yahoo.com - February 27 at 3:18 PM
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel